Clinical Trial Update: Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 2/3 study evaluating platelet-rich fibrin with 1.2% rosuvastatin for chronic periodontitis; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED